Showing results (201-210 of 264) with videos related to

Sort By:
Pageof 27
Biological Psychiatry|August 1, 2006
Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomographyDara M Cannon, Masanori Ichise, Stephen J Fromm, et al.
Brain : a Journal of Neurology|May 12, 2012
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndromeAlicja Lerner, Anto Bagic, Janine M Simmons, et al.
Neuroimage|November 1, 2005
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometryAllison C Nugent, Michael P Milham, Earle E Bain, et al.
Bipolar Disorders|November 27, 2008
A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depressionM Kathleen Holmes, Kristine Erickson, David A Luckenbaugh, et al.
The International Journal of Neuropsychopharmacology|January 13, 2022
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant DepressionGuang Chen, Li Chen, Yun Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2023
Characterization of Selective M<sub>5</sub> Acetylcholine Muscarinic Receptor Modulators on Dopamine Signaling in the StriatumVivien Zell, Greetje Teuns, Alexandra Stormy Needham, et al.
Psychopharmacology|February 3, 2018
Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled studyRandall L Morrison, Maggie Fedgchin, Jaskaran Singh, et al.
JAMA Psychiatry|December 29, 2017
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical TrialElla J Daly, Jaskaran B Singh, Maggie Fedgchin, et al.
JAMA Psychiatry|July 2, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical TrialAdam Janik, Xin Qiu, Rosanne Lane, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2013
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionAllison C Nugent, Earle E Bain, Paul J Carlson, et al.
Pageof 27